Dennis Pietronigro, Ph.D.

Founder, Chief Science Officer and Director

Dennis Pietronigro, Ph.D., Founder, Chief Science Officer and Director, has 25 years of research and development experience in anti-cancer therapeutics, immunology, and cell biology. Prior to founding DTI, Dr. Pietronigro was Vice President of Research and Development at NYGene Corporation, a developer of immunology products. He was previously a Research Assistant Professor in the Department of Neurosurgery at New York University Medical School. Dr. Pietronigro received his Ph.D. in molecular pathology from NYU Medical School and was a Postdoctoral Fellow of Cancer Chemotherapy at Yale University.